Phase II study of adjuvant gemcitabine plus docetaxel (GD) for completely resected stage I-IV high grade uterine leiomyosarcoma (HGuLMS)

被引：0
|
作者：
Hensley, M. L. [1 ]
Larkin, J. [1 ]
Ishill, N. [1 ]
Abu-Rustum, N. [1 ]
Sabbatini, P. [1 ]
Konner, J. [1 ]
Tew, W. [1 ]
Spriggs, D. [1 ]
Aghajanian, C. A. [1 ]
机构：
[1] Memor Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5591
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer Phase I Study
    Ueno, Makoto
    Morinaga, Soichiro
    Hashimoto, Yusuke
    Umemoto, Kumiko
    Sasahira, Naoki
    Saiura, Akio
    Seyama, Yasuji
    Honda, Goro
    Ioka, Tatsuya
    Takahashi, Hidenori
    Miyamoto, Atsushi
    Nakamori, Shoji
    Unno, Michiaki
    Takadate, Tatsuyuki
    Mizuno, Nobumasa
    Shimizu, Yasuhiro
    Ueno, Hideki
    Sugiyama, Masanori
    Fukutomi, Akira
    Shimizu, Satoshi
    Okusaka, Takuji
    Furuse, Junji
    PANCREAS, 2021, 50 (01) : 83 - 88
  • [32] Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer
    Yoon, Shinkyo
    Yoo, Changhoon
    Ryu, Min-Hee
    Kang, Myoung Joo
    Ryoo, Baek-Yeol
    Park, Sook Ryun
    Yook, Jeong Hwan
    Oh, Sung Tae
    Yoo, Moon-Won
    Kim, Byung Sik
    Kang, Yoon-Koo
    GASTRIC CANCER, 2017, 20 (01) : 182 - 189
  • [33] Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: A phase II study
    Syrigos, Konstantinos N.
    Konstantinou, Marios
    Sepsas, Evangellos
    Papamichales, George
    Loullias, Achilleas
    Belenis, Ionas
    Skottis, Ionas
    Charpidou, Andriani
    Roussos, Charalambos
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2887 - 2892
  • [34] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Reiko Sakurai
    Yoshio Tomizawa
    Akihiro Yoshii
    Yosuke Miura
    Hiroaki Tsurumaki
    Kyoichi Kaira
    Noriaki Sunaga
    Osamu Kawashima
    Takeshi Hisada
    Masanobu Yamada
    Ryusei Saito
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 103 - 109
  • [35] Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer
    Makoto Sonobe
    Ken-ichi Okubo
    Satoshi Teramukai
    Kazuhiro Yanagihara
    Masaaki Sato
    Toshihiko Sato
    Fengshi Chen
    Kiyoshi Sato
    Takuji Fujinaga
    Tsuyoshi Shoji
    Mitsugu Omasa
    Hiroaki Sakai
    Ryo Miyahara
    Toru Bando
    Hiroshi Date
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1199 - 1206
  • [36] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Sakurai, Reiko
    Tomizawa, Yoshio
    Yoshii, Akihiro
    Miura, Yosuke
    Tsurumaki, Hiroaki
    Kaira, Kyoichi
    Sunaga, Noriaki
    Kawashima, Osamu
    Hisada, Takeshi
    Yamada, Masanobu
    Saito, Ryusei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 103 - 109
  • [37] Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
    Park, Cheol-Kyu
    Oh, Hyung-Joo
    Yoo, Seung Soo
    Lee, Shin Yup
    Lee, Sang Hoon
    Kim, Eun Young
    Lee, Sung Yong
    Choi, Juwhan
    Lee, Min Ki
    Kim, Mi-Hyun
    Jang, Tae Won
    Chung, Chaeuk
    Oh, In-Jae
    Kim, Young-Chul
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (08) : 1606 - 1618
  • [38] A feasibility study of adjuvant carboplatin (C) plus gemcitabine (G) in completely resected stage IB-III non-small-cell lung cancer (NSCLC)
    Horiike, A.
    Ohyanagi, F.
    Okano, Y.
    Satoh, Y.
    Okumura, S.
    Ishikawa, Y.
    Nakagawa, K.
    Horai, T.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503
    Kubota, Kaoru
    Kunitoh, Hideo
    Seto, Takashi
    Shimada, Naoki
    Tsuboi, Masahiro
    Ohhira, Tatsuo
    Okamoto, Hiroaki
    Masuda, Noriyuki
    Maruyama, Riichiroh
    Shibuya, Masahiko
    Watanabe, Koshiro
    LUNG CANCER, 2020, 141 : 32 - 36
  • [40] Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer
    Sonobe, Makoto
    Okubo, Ken-ichi
    Teramukai, Satoshi
    Yanagihara, Kazuhiro
    Sato, Masaaki
    Sato, Toshihiko
    Chen, Fengshi
    Sato, Kiyoshi
    Fujinaga, Takuji
    Shoji, Tsuyoshi
    Omasa, Mitsugu
    Sakai, Hiroaki
    Miyahara, Ryo
    Bando, Toru
    Date, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1199 - 1206
12345